Home/Filings/4/0001048477-23-000037
4//SEC Filing

FUCHS HENRY J 4

Accession 0001048477-23-000037

CIK 0001048477other

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 1:59 PM ET

Size

4.8 KB

Accession

0001048477-23-000037

Insider Transaction Report

Form 4
Period: 2023-08-10
FUCHS HENRY J
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-08-10$90.43/sh12,000$1,085,111176,187 total
Footnotes (1)
  • [F1]The price in column 4 is the weighted average price. The price actually received ranged from $90.40 to $90.515. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001197355

Filing Metadata

Form type
4
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 1:59 PM ET
Size
4.8 KB